Edition:
United Kingdom

MacroGenics Inc (MGNX.OQ)

MGNX.OQ on NASDAQ Stock Exchange Global Select Market

17.79USD
23 Oct 2018
Change (% chg)

$-0.34 (-1.88%)
Prev Close
$18.13
Open
$17.79
Day's High
$17.79
Day's Low
$17.79
Volume
3,614
Avg. Vol
106,423
52-wk High
$32.57
52-wk Low
$16.16

Chart for

About

MacroGenics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing monoclonal antibody-based therapeutics for the treatment of cancer, as well as various autoimmune disorders and infectious diseases. The Company develops therapeutic product candidates using its antibody-based technology... (more)

Overall

Beta: 2.78
Market Cap(Mil.): $659.43
Shares Outstanding(Mil.): 36.80
Dividend: --
Yield (%): --

Financials

  MGNX.OQ Industry Sector
P/E (TTM): -- 85.35 33.64
EPS (TTM): -4.18 -- --
ROI: -49.45 0.18 14.27
ROE: -52.35 1.14 15.99

BRIEF-MacroGenics Posts Qtrly Net Loss Per Common Share Of $1.34

* MACROGENICS PROVIDES UPDATE ON CORPORATE PROGRESS AND 1ST QUARTER 2018 FINANCIAL RESULTS

07 May 2018

Earnings vs. Estimates